In the competitive world of pharmaceutical and medtech sales, developing an effective market access strategy requires a customised and agile approach.
Healthcare payers want therapies that are clinically and economically better than the existing alternatives, together with real-world outcomes data to back any claims about a medicine’s superiority.
Simulation enables market access teams to:
- Consider the implications of products on the wider healthcare market
- Understand the impact of the changing healthcare market on products
- Communicate the value of products to decision makers who influence adoption
Robust simulation models developed for health economics can also be utilized in sales presentations to healthcare payers, providing an engaging, dynamic and visual representation of the impact of treatments on localized populations and patients.
In turn, this enables a helpful dialogue between clinicians, administrators and the pharma company which supports understanding and increases the chances of adoption and reimbursement.
SIMUL8 Corporation works with some of the top pharmaceutical and medical device companies including:
- Johnson and Johnson
- Boston Scientific
Disease areas include:
- Hepatitis C
Case study example
The University Medical Center Hamburg-Eppendorf, based in Hamburg, Germany, utilized SIMUL8 to assess the costs of compression therapy in venous leg ulcers in Germany and simulate the economic effects of regional disparities in healthcare.